About

Mighty Capital is an early-growth Silicon Valley venture capital firm. We look for companies with:
  • a strong leadership team,
  • proven product-market fit, and
  • a clear go-to-market strategy.
We are investors in Digital Ocean, Amplitude and MissionBio. Amplitude calls us the “best value for the dollar invested" and says that our network brought them millions of dollars in revenue. The combination of our diverse partnership expertise and our exclusive access to a global business acceleration platform, Products That Count, helps our portfolio drive sales, hire talent, validate ideas, and exit via corporate M&A. That is why top-tier venture firms like USVP, Mayfield and Aligned Partners invited us to co-invest with them, and why Business Insider says we’ve come up with “a new way of doing venture capital.” If you or someone you know runs a company that meets those criteria, we’d love to hear about it! The best way to get in touch with us is via a mutual connection, most likely a current investor or your law firm. If that’s not an option, then email dealflow@mighty.capital.

Blog


May 21, 2019

Cancer is smart. Yes, you read that right.

The disease isn’t intelligent in the traditional sense — but cancer cells are adaptable, ‘learning’ from their environment and constantly evolving to improve survival. While targeted therapy can be effective at first, this evolution means that treatment resistance and disease progression remain a challenge.

To effectively combat cancer — to both detect it sooner and develop the most impactful, dynamic therapies — we need to be able to understand it. This means tracking the progression of each and every cancerous cell.

Read More

May 7, 2019

How top marketers are winning against digital-only disruptors by bringing location to the cloud.

Read More

May 3, 2019

Listen to the Product Guru Bruce Cleveland discuss the importance of Bridging The Traction Gap for startups and investors alike:

  • Building the framework for success factors that turn startups into sustainable businesses
  • What it takes for companies with promising tech to become industry powerhouses
  • The difference between seeking out investors and having investors come to you
Read More

April 24, 2019

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing as a first-line diagnostic test for critically ill babies.

Read More

April 12, 2019

Mighty Capital, whose founder and managing partner is SC Moatti, has its first liquidity event. SC tells Women’s PE Briefs that the firm sold a small portion of its first investment, Amplitude.

Read More

April 12, 2019

Hear from the leader as one of Mighty Capital’s portfolio companies share his experience delivering customer delight through product:

  • The power of authentic customer delight
  • Driving efficiencies for growth with a personal touch
  • Staying true to your company’s mission and core values

To effectively scale a business, it’s critical to focus on providing customer delight with marketing tactics that are rooted in the product’s core value.

Read More

April 4, 2019
Idea to IPO’s mission is to promote entrepreneurship, support entrepreneurs, build community, & provide value in the Silicon Valley startup ecosystem.
SC Moatti participated as a panelist during the 2/28/2019 Venture Capital Panel discussing the hottest funding trends of 2019.
Read More

March 29, 2019

Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and companion diagnostics development.

Read More

February 21, 2019

Our Managing Partner SC Moatti wrote an editorial for Barron’s discussing the impact of mega-funds on the rest of the venture capital ecosystem. Here’s an abstract: In venture capital, the assumption used to be that to survive against the likes of Sequoia and the Vision Fund, funds need to get big. Really big. However, it’s become nearly impossible to remain competitive in the go-big-or-go-home scenarios. It’s no longer a winner-take-all market. The insightful, agile, lateral looking investor, however, has plenty of room to move and grow into the future. For the shrewd venture investor, new strategies—ones that leverage inherent ecosystem value —make the most sense.

Read More

February 21, 2019

Having insights into how investors think about assessing a startup team will also help you think about designing your organization and hiring for the right qualities. I’ll break down the questions investors may ask themselves into 4 easy to remember categories.

Read More

© 2020 Mighty Capital All Rights Reserved